News & Updates

In dietary trials for inflammatory bowel disease (IBD), there appears to be some evidence of a benefit with partial enteral nutrition for induction and maintenance of remission in Crohn’s disease (CD), according to a study. However, lowering intake of red meat and refined carbohydrates does not exert any effect in terms of reducing the risk of CD relapse.

A recent decrease in total cholesterol levels may signal an aggravated risk of pancreatic cancer, reports a study. On the other hand, high serum cholesterol in the preceding years may exert a protective effect against pancreatic cancer.

A gut microbiota–derived synbiotic formula developed by researchers from the Chinese University of Hong Kong (CUHK) is shown in a randomized controlled trial to reduce the risk of bacterial and viral infections, including COVID-19, reduce the risk of adverse events (AEs) after COVID-19 vaccination, restore healthy gut microbiota, and provide other health benefits.

A smoking cessation program led by a pharmacist in a specialty medical home is feasible and may even lead to successful quit attempts and improved use of inflammatory bowel disease (IBD) medications, suggest the results of a study.

Oral ENT-01 safely and significantly improves constipation in patients with Parkinson’s disease (PD), results of a phase IIb study have shown.

A recent meta-analysis has showed little evidence supporting the use of probiotics containing a combination of Lactobacillus acidophilus and L. bulgaricus for the treatment of diarrhoea.

Random histological sampling from the esophagogastric junction (EGJ) appears to hold low clinical relevance in patients who have undergone successful endoscopic eradication of all visible Barrett’s esophagus (BE), given that the incidence of intestinal metaplasia at the EGJ does not pose a higher risk of disease recurrence, according to a study.